Towards Elimination of Malaria in Tanzania (TEMT)


Despite significant progress, Tanzania is still a major malaria-burdened country. It aspires to further accelerate progress towards malaria elimination through innovative strategies and investments in research, vaccine development, and multi-country collaborations. Switzerland supports capacity building, evidence creation, systems to strengthen vector control, case management, surveillance, monitoring and evaluation, multi-sectoral collaboration and cross-border initiatives upon request by the Government.

Región/País Tema Período Presupuesto
Tanzania
Salud
Governance
nothemedefined
Malaria
Fortalecimiento del sistema sanitario
Política del sector público
01.05.2025 - 30.04.2030
CHF  5’900’000
Contexto Over the past two decades, Tanzania has strengthened its public health infrastructure and community initiatives like distributing insecticidetreated bednets, thus reducing malaria transmission. From 2015 to 2020, under-five malaria prevalence fell from 14% to 8.1%, under-five mortality from 67 to 43 per 1,000 live births, annual in-patient facility cases from 7.7 to 5.9 million, and malaria incidence from 162 to 106 per 1,000 people. Despite progress, challenges like drug and insecticide resistance as well as climate-driven outbreaks persist, requiring further innovations, better resource mobilization, and sustained political commitment. TEMT supports the National Malaria Control Program (NMCP) and the Zanzibar Malaria Elimination Program (ZAMEP) with targeted technical assistance for strategic malaria interventions under the respective Ministries of Health.
Objetivos To contribute to the reduction of malaria morbidity and mortality in Tanzania Mainland and malaria elimination in Zanzibar in line with the respective strategic plans.
Grupos destinarios

For disease burden: Tanzania’s population of ~70 million

For systems and skills: Ministries of Health - Mainland and Zanzibar (specifically, NMCP and ZAMEP); President’s Office Regional Administration and Local Government (PO-RALG); Zanzibar!President’s Office – Regional Administration and Special Departments (PO-RASD).

Efectos a medio plazo

Outcome 1: Strengthened evidencebased strategies and innovative surveillance-response efforts for malaria control and elimination

Outcome 2: Enhanced Multi-sectoral engagement and coordination for sustainable malaria control and elimination.

Resultados

Resultados previstos:  

  1. 233 additional shehias1 (n=388, from 58 to 291) achieving zero local malaria transmission in Zanzibar
  2. 20 additional councils (n=184, from 70 to 90) achieving low malaria transmission risk status in Tanzania mainland
  3. At least 8 non-health sectors (n=27) implementing and documenting-malaria smart activities in 15 high burden mainland councils (n=57)
  4. At least 10 regional and global scientific publications on the Tanzanian malaria experience


Resultados de las fases anteriores:  

  1. National level: Introduced targeted planning based on microstratification, structured engagement of sectors beyond health, and multi-country cross-border joint control efforts
  2. In high burden strata: A 53% reduction in malaria prevalence among school-aged children through generation of evidence-based strategies for preventive treatment
  3. In moderate-risk strata: A 53% reduction in the malaria positivity rate among pregnant women 
  4. In low-risk strata: A 31% decrease in malaria incidence among individuals aged 5+ through application of biolarvicides
  5. Bolstered NMCP and ZAMEP to raise resources leveraging CHF 83 for every CHF 1 invested by Switzerland


Dirección / Officina Federal responsable COSUDE
Contrapartes del proyecto Contraparte del contrato
Sector privado
Institución académica y de investigación suiza
  • Sector privado extranjero Sur/Este
  • Swiss Tropical and Public Health Institute


Coordinación con otros proyectos y actores The Ifakara Health Institute (IHI); the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM); the U.S. President's Malaria Initiative (PMI); the Gates Foundation (GF); the East African Community’s Great Lakes Malaria Initiative (EAC’s GLMI); the RBM Partnership to End Malaria (formerly, the Roll Back Malaria Partnership); the African Leaders Malaria Alliance (ALMA).
Presupuesto Fase en curso Presupuesto suizo CHF    5’900’000 Presupuesto actual suizo ya emitido CHF    0 Presupuesto inclusive contrapartes del proyecto CHF    858’800’000 Total del proyecto desde la primera fase Presupuesto suizo CHF   6’463’515 Presupuesto inclusive contrapartes del proyecto CHF   19’594’771
Fases del proyecto Fase 2 01.05.2025 - 30.04.2030   (Fase en curso) Fase 1 01.12.2018 - 30.04.2025   (Completed)